MEG3 and MEG8 aberrant methylation in an infant with neuroblastoma
- PMID: 32667684
- DOI: 10.1002/pbc.28328
MEG3 and MEG8 aberrant methylation in an infant with neuroblastoma
References
REFERENCES
-
- Irwin MS, Park JR. Neuroblastoma: paradigm for precision medicine. Pediatr Clin North Am. 2015;62:225-256.
-
- Ahmed AA, Zhang L, Reddivalla N, Hetherington M. Neuroblastoma in children: update on clinicopathologic and genetic prognostic factors. Pediatr Hematol Oncol. 2017;34:165-185.
-
- Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203-216.
-
- Park JR, Bagatell R, London WB, et al. Children's Oncology Group's 2013 blueprint for research: neuroblastoma. Pediatr Blood Cancer. 2013;60:985-993.
-
- Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol. 1993;11:1466-1477.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
